Literature DB >> 9220165

Vaginal formulations of carrageenan protect mice from herpes simplex virus infection.

V R Zacharopoulos1, D M Phillips.   

Abstract

The observations from the present study indicate that vaginal formulations of the sulfated polysaccharide carrageenan are highly effective in protecting mice from herpes simplex virus type 2 (HSV-2) infection. Test formulations were placed in the vaginas of progestin-treated mice prior to inoculation with HSV-2. Infection was determined by the presence of inflammation in the genital region and death. At a dose of virus that infected half of the control animals, 1% solutions of either lambda, kappa, or iota carrageenan prevented infection of almost all of the animals. Concentrations as low as 0.05% protected a large majority of the mice. At a dose of virus that infected all of the control mice, 1% solutions of carrageenans protected 85% of the inoculated mice. Other sulfated polysaccharides were less effective or showed no efficacy in preventing HSV-2 infection. These findings suggest that a vaginal formulation of carrageenan may be effective in blocking sexual transmission of HSV-2 in women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220165      PMCID: PMC170551          DOI: 10.1128/cdli.4.4.465-468.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  17 in total

1.  EFFECT OF SYNTHETIC AND BIOLOGICAL POLYANIONS ON HERPES SIMPLEX VIRUS.

Authors:  A J NAHMIAS; S KIBRICK; P BERNFELD
Journal:  Proc Soc Exp Biol Med       Date:  1964-04

2.  Inactivation of herpes simplex viruses by nonionic surfactants.

Authors:  S S Asculai; M T Weis; M W Rancourt; A B Kupferberg
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

3.  Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus.

Authors:  M Baba; R Snoeck; R Pauwels; E de Clercq
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

4.  Cell-mediated infection of cervix derived epithelial cells with primary isolates of human immunodeficiency virus.

Authors:  X Tan; D M Phillips
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.

Authors:  M A Walz; R W Price; A L Notkins
Journal:  Science       Date:  1974-06-14       Impact factor: 47.728

6.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

7.  Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2.

Authors:  M R McDermott; J R Smiley; P Leslie; J Brais; H E Rudzroga; J Bienenstock
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

8.  Sulfated polysaccharides inhibit lymphocyte-to-epithelial transmission of human immunodeficiency virus-1.

Authors:  R Pearce-Pratt; D M Phillips
Journal:  Biol Reprod       Date:  1996-01       Impact factor: 4.285

9.  Studies of adhesion of lymphocytic cells: implications for sexual transmission of human immunodeficiency virus.

Authors:  R Pearce-Pratt; D M Phillips
Journal:  Biol Reprod       Date:  1993-03       Impact factor: 4.285

10.  Latent herpes simplex virus in the central nervous system of rabbits and mice.

Authors:  F B Knotts; M L Cook; J G Stevens
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

View more
  31 in total

1.  The Development of Microbicides for Clinical Use to Prevent Sexually Transmitted Diseases.

Authors:  David M. Phillips; Robin A. Maguire
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

2.  Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa.

Authors: 
Journal:  Contraception       Date:  2010-05-26       Impact factor: 3.375

3.  Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.

Authors:  José A Fernández-Romero; Ciby J Abraham; Aixa Rodriguez; Larisa Kizima; Ninochka Jean-Pierre; Radhika Menon; Othell Begay; Samantha Seidor; Brian E Ford; Pedro I Gil; Jennifer Peters; David Katz; Melissa Robbiani; Thomas M Zydowsky
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

4.  Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.

Authors:  Regine Sitruk-Ware; Vivian Brache; Robin Maguire; Horacio Croxatto; Narender Kumar; Sushma Kumar; Juan Carlos Montero; Ana Maria Salvatierra; David Phillips; Anibal Faundes
Journal:  Contraception       Date:  2007-04-18       Impact factor: 3.375

5.  Dendrimers, a new class of candidate topical microbicides with activity against herpes simplex virus infection.

Authors:  N Bourne; L R Stanberry; E R Kern; G Holan; B Matthews; D I Bernstein
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

6.  Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide.

Authors:  C Coggins; K Blanchard; F Alvarez; V Brache; E Weisberg; P H Kilmarx; M Lacarra; R Massai; D Mishell; A Salvatierra; P Witwatwongwana; C Elias; C Ellertson
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

7.  Evaluation of disease resistance and tolerance to elevated temperature stress of the selected tissue-cultured Kappaphycus alvarezii Doty 1985 under optimized laboratory conditions.

Authors:  Azhani Azizi; Nursyuhaida Mohd Hanafi; Mohd Nazir Basiran; Chee How Teo
Journal:  3 Biotech       Date:  2018-07-17       Impact factor: 2.406

8.  In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission.

Authors:  Charlene S Dezzutti; V Nicole James; Artur Ramos; Sharon T Sullivan; Aladin Siddig; Timothy J Bush; Lisa A Grohskopf; Lynn Paxton; Shambavi Subbarao; Clyde E Hart
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

9.  Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer.

Authors:  Natalia Teleshova; Theresa Chang; Albert Profy; Mary E Klotman
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

10.  Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study.

Authors:  Vivian Brache; Horacio Croxatto; Narender Kumar; Regine Sitruk-Ware; Leila Cochón; Veronica Schiappacasse; Irving Sivin; Carla Muñoz; Robin Maguire; Anibal Faundes
Journal:  Contraception       Date:  2008-11-21       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.